Lorena Rossi Selected Research

Drug-Related Side Effects and Adverse Reactions

3/2017

Is polypharmacy an independent risk factor for adverse outcomes after an emergency department visit?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lorena Rossi Research Topics

Disease

11	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 06/2014
9	Neoplasms (Cancer) 01/2021 - 10/2005
3	Colonic Neoplasms (Colon Cancer) 01/2013 - 08/2005
2	Ovarian Epithelial Carcinoma 01/2021 - 12/2018
2	Neoplasm Metastasis (Metastasis) 12/2020 - 04/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 10/2016
2	Testicular Neoplasms (Testicular Cancer) 01/2020 - 05/2017
1	Carcinoma (Carcinomatosis) 01/2021
1	Dementia (Dementias) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Infections 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Premature Aging 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2018
1	Frailty 03/2017
1	Drug-Related Side Effects and Adverse Reactions 03/2017
1	Stomatitis 10/2016

Drug/Important Bio-Agent (IBA)

6	enzalutamideIBA 12/2020 - 12/2014
4	abirateroneIBA 01/2018 - 06/2014
3	Hormones (Hormone)IBA 12/2020 - 05/2017
3	Androgen Receptors (Androgen Receptor)IBA 12/2020 - 01/2018
3	Biological ProductsIBA 01/2020 - 05/2017
3	Fluorouracil (Carac)FDA LinkGeneric 12/2018 - 08/2005
2	Biomarkers (Surrogate Marker)IBA 11/2019 - 10/2017
2	Pharmaceutical PreparationsIBA 03/2017 - 09/2007
2	Chromogranin AIBA 12/2014 - 06/2014
1	Alkylating AgentsIBA 01/2021
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	AndrogensIBA 12/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	NivolumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 11/2019
1	Topotecan (Hycamtin)FDA LinkGeneric 12/2018
1	Leucovorin (Folinic Acid)FDA Link 12/2018
1	PlatinumIBA 12/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2018
1	fluoromethylcholineIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 10/2017
1	Vitamin D FDA LinkGeneric 05/2017
1	Everolimus FDA Link 10/2016
1	Hemoglobins (Hemoglobin)IBA 04/2015
1	Docetaxel (Taxotere)FDA Link 06/2014
1	A-factor (Streptomyces)IBA 09/2007
1	AntimetabolitesIBA 09/2007
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2005
1	Interferon-gamma (Interferon, gamma)IBA 10/2005
1	AntigensIBA 10/2005
1	dechromose-A chrommycin A3IBA 10/2005
1	Protein Kinase InhibitorsIBA 08/2005
1	Carcinoembryonic AntigenIBA 08/2005
1	StaurosporineIBA 08/2005

Therapy/Procedure

9	Castration 12/2020 - 06/2014
6	Therapeutics 12/2020 - 01/2018
6	Drug Therapy (Chemotherapy) 01/2020 - 01/2013
2	Immunotherapy 01/2020 - 12/2017
1	Self-Help Devices (Assistive Technology) 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2020
1	Polypharmacy 03/2017
1	Drug Tapering 10/2016
1	Adjuvant Chemotherapy 01/2013